Evonik scoops CMO Leadership Award for fourth year in a row

The company wins awards in all six categories — capabilities, compatibility, expertise, quality, reliability and service

Winners are chosen through market research based on feedback from pharmaceutical companies that utilize outsourcing services. Evonik’s success confirms the company’s outstanding performance and value to the pharmaceutical and life science industries.

Life Science Leader magazine and Outsourced Pharma teamed up with Industry Standard Research (ISR) to assess more than 70 CMOs across 23 performance metrics as part of ISR’s 2021 Contract Manufacturing Quality Benchmarking survey of global pharmaceutical and biotechnology companies.

For the fourth consecutive year, participating companies voted for Evonik to earn awards for its capabilities, compatibility, expertise, quality, reliability and service.

As one of the world’s top CMOs for APIs and intermediates, the Health Care business line is part of the life science division Nutrition & Care and represents a key growth lever for Evonik. To meet growing customer demand for its CMO services, Evonik is expanding its production capacity at two sites in Germany, as announced in May 2020.

“To be recognized by our customers as a leader for the fourth time in a row is a tremendous honour,” said Thomas Riermeier, head of Evonik’s Health Care business line.

To address the specific needs of large or complex projects, Evonik has established a broad portfolio of advanced technologies which can be combined to support multi-step API synthesis. These technologies include continuous processes, fermentation, PEGs and mPEGs, catalysts, biocatalysts, cryogenic chemistry and polymer APIs.